Citations

Mayo Clinic

Showing 10 of 108572 citations.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes
Cerhan, James R. , Maurer, Matthew J. , Link, Brian K. , Feldman, Andrew L. , Habermann, Thomas M. , Jaye, David L. , Burack, Richard , McDonnell, Timothy J. , Vega, Francisco , Chapman, Jennifer R. , Leonard, John P. , Bernal‐Mizrachi, Leon , Alderuccio, Juan Pablo , Riska, Shaun M., Gysbers, Brianna, Lunde, Julianne J. , Reicks, Tanner W., Ayers, Amy , O’Leary, Colin B. , Yost, Kathleen J. , Nowakowski, Grzegorz S. , Ruan, Jia , Koff, Jean L. , Thompson, Carrie A. , Cohen, Jonathon B. , Lossos, Izidore S. , Friedberg, Jonathan W. , Martin, Peter W., Flowers, Christopher R. , Burack, W Richard , Syrbu, Sergei , Vij, Kiran R , Bernal-Mizrachi, Leon , Witzig, T.E. , Weiner, George , Wang, Yucai , Alderuccio, Juan Pablo , Slager, Susan L , Liu, Hongfang , Chihara, Dai , Koff, Jean L , Casulo, Carla , Thompson, Carrie A , Cohen, Jonathon B , Kahl, Brad S , Lossos, Izidore S , Feldman, Andrew L , Maurer, Matthew , Cerhan, James R , Vega, Francisco , Link, Brian K , Habermann, Thomas , Jaye, David L , Syrbu, Sergei , Inghirami, Giorgio , Farooq, Umar , Witzig, Thomas E. , Weiner, George J. , Wang, Yucai , Slager, Susan L. , Larson, Melissa C. , Liu, Hongfang , Chihara, Dai , Casulo, Carla , Kahl, Brad S. , Nastoupil, Loretta J. , Martin, Peter

American Journal of Hematology | January 13, 2024 | Volume: 99 | Issue: 3 | Pages: 408-421

10.1002/ajh.27202 | PMID 38217361 Get It

AbstractTo address the current and long‐term unmet health needs of the growing population of non‐Hodgkin lymphoma (NHL) patients, we established the Lymphoma Epidemiology of Outcomes (LEO) cohort study (NCT02736357; https://leocohort.org/). A total of 7735 newly diagnosed patients aged 18 years and older with NHL were prospectively enrolled from 7/1/2015 to 5/31/2020 at 8 academic centers in the United States. The median age at diagnosis was 62 years (range, 18–99). Participants came from 49 US states and included 538 Black/African‐Americans (AA), 822 Hispanics (regardless of race), 3386 women, 716 age <40 years, and 1513 rural residents. At study baseline, we abstracted clinical, pathology, and treatment data; banked serum/plasma (N = 5883, 76.0%) and germline DNA (N = 5465, 70.7%); constructed tissue microarrays for four major NHL subtypes (N = 1189); and collected quality of life (N = 5281, 68.3%) and epidemiologic risk factor (N = 4489, 58.0%) data. Through August 2022, there were 1492 deaths. Compared to population‐based SEER data (2015–2019), LEO participants had a similar distribution of gender, AA race, Hispanic ethnicity, and NHL subtype, while LEO was underrepresented for patients who were Asian and aged 80 years and above. Observed overall survival rates for LEO at 1 and 2 years were similar to population‐based SEER rates for indolent B‐cell (follicular and marginal zone) and T‐cell lymphomas, but were 10%–15% higher than SEER rates for aggressive B‐cell subtypes (diffuse large B‐cell and mantle cell). The LEO cohort is a robust and comprehensive national resource to address the role of clinical, tumor, host genetic, epidemiologic, and other biologic factors in NHL prognosis and survivorship.
Enhancing the quality and reproducibility of research: How to work effectively with medical and data librarians
Throgmorton, Kaitlin , Festa, Natalia , Doering, Michelle , Carpenter, Christopher R. , Gill, Thomas M. , Throgmorton, Kaitlin Fender , Gill, Thomas M , Carpenter, Christopher R

Journal of the American Geriatrics Society | January 13, 2024 | Volume: 72 | Issue: 3 | Pages: 965-970

10.1111/jgs.18741 | PMID 38217346 Get It

Surgical Treatment of Hemifacial Spasm via Microvascular Decompression of a Large, Ectatic Vertebral Artery
Bauman, Megan M. J. , Carlstrom, Lucas P. , Link, Michael J., Bauman, Megan , Link, Michael J.

Journal of Neurological Surgery Reports | January 13, 2024 | Volume: 85 | Issue: 01 | Pages: e23-e24

10.1055/a-2244-1143 | PMID 38348014 Get It

AbstractHemifacial spasm is a neuromuscular disorder caused by compression of the facial nerve at the nerve root entry zone, often due to ectatic or aberrant vasculature. Pathologic compression of the nerve–brainstem interface results in involuntary, paroxysmal contractions of ipsilateral facial muscles that may cause considerable impairments in quality of life. For those with severe symptoms, have positive imaging demonstrating vascular compression, or who fail other management modalities,1 2 3 4 microvascular decompression offers potential definitive treatment.5 6 Traditionally, nonabsorbable packing agent is used to pack between the nerve and offending vascular structure. However, for large and more complex arterial structures, simple nonabsorbable padding is often not sufficient.In this operative video, we demonstrate microvascular decompression for intractable hemifacial spasm in a 52-year-old female using a specialized sling tacked to the petrous dura for management of a large, ectatic vertebral artery. Following a standard left retrosigmoid craniotomy, an atheromatous ectatic vertebral artery was identified. We fashioned a bovine pericardium sling around the vessel and used a permanent aneurysm clip to secure it to an incision portion of petrous dura. We subsequently identified potential additional facial nerve root compression by anterior inferior cerebellar artery (AICA) and posterior inferior cerebellar artery (PICA) branches, which were elevated and secured using Teflon felt packing. Following elevation of all three vessels, the lateral spread response resolved. At 2 weeks postoperatively, the patient reported substantial relief in her hemifacial spasms and endorsed highly improved quality of life.
An Analysis of the Use of Gender-Inclusive Terminology Amongst Radiology Vendors: Moving Forward From “Women’s Imaging”
Zaki-Metias, Kaitlin M. , Sharma, Sonali , Kolof, Hanna, Yan, Tyler D. , Laule, Cornelia , Carroll, Evelyn F. , Yong‐Hing, Charlotte J. , Yong-Hing, Charlotte J , Narayan, Anand K. , Spalluto, Lucy B.

Canadian Association of Radiologists Journal | January 12, 2024 | Volume: 75 | Issue: 3 | Pages: 671-672

10.1177/08465371231226164 | PMID 38216858 Get It

Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia
Martin, Peter R. , Duffy, Joseph R. , Botha, Hugo , Pham, Nha Trang Thu, Schwarz, Christopher G. , Jack, Clifford R. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Tetzloff, Katerina A. , Duffy, Joseph R , Botha, Hugo , Thu Pham, Nha Trang, Schwarz, Christopher G , Jack, Clifford R , Josephs, Keith A , Whitwell, Jennifer , Utianski, Rene L. , Clark, Heather M. , Machulda, Mary M. , Senjem, Matthew L.

Brain | January 12, 2024 | Volume: 147 | Issue: 5 | Pages: 1696-1709

10.1093/brain/awae016 | PMID 38217867 Get It

Abstract Progressive apraxia of speech (PAOS) is a neurodegenerative motor-speech disorder that most commonly arises from a four-repeat tauopathy. Recent studies have established that progressive apraxia of speech is not a homogenous disease but rather there are distinct subtypes: the phonetic subtype is characterized by distorted sound substitutions, the prosodic subtype by slow and segmented speech and the mixed subtype by a combination of both but lack of predominance of either. There is some evidence that cross-sectional patterns of neurodegeneration differ across subtypes, although it is unknown whether longitudinal patterns of neurodegeneration differ. We examined longitudinal patterns of atrophy on MRI, hypometabolism on 18F-fluorodeoxyglucose-PET and tau uptake on flortaucipir-PET in a large cohort of subjects with PAOS that had been followed for many years. Ninety-one subjects with PAOS (51 phonetic, 40 prosodic) were recruited by the Neurodegenerative Research Group. Of these, 54 (27 phonetic, 27 prosodic) returned for annual follow-up, with up to seven longitudinal visits (total visits analysed = 217). Volumes, metabolism and flortaucipir uptake were measured for subcortical and cortical regions, for all scans. Bayesian hierarchical models were used to model longitudinal change across imaging modalities with PAOS subtypes being compared at baseline, 4 years from baseline, and in terms of rates of change. The phonetic group showed smaller volumes and worse metabolism in Broca’s area and the striatum at baseline and after 4 years, and faster rates of change in these regions, compared with the prosodic group. There was also evidence of faster spread of hypometabolism and flortaucipir uptake into the temporal and parietal lobes in the phonetic group. In contrast, the prosodic group showed smaller cerebellar dentate, midbrain, substantia nigra and thalamus volumes at baseline and after 4 years, as well as faster rates of atrophy, than the phonetic group. Greater hypometabolism and flortaucipir uptake were also observed in the cerebellar dentate and substantia nigra in the prosodic group. Mixed findings were observed in the supplementary motor area and precentral cortex, with no clear differences observed across phonetic and prosodic groups. These findings support different patterns of disease spread in PAOS subtypes, with corticostriatal patterns in the phonetic subtype and brainstem and thalamic patterns in the prosodic subtype, providing insight into the pathophysiology and heterogeneity of PAOS.
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non–Small-Cell Lung Cancer
Stinchcombe, Thomas E. , Wang, Xiaofei , Damman, Bryce , Mentlick, Jennifer, Landreneau, Rodney J., Wigle, Dennis A. , Conti, Massimo , Ashrafi, Ahmad S., Liberman, Moïshe , Mitchell, John D. , Keenan, Robert J. , Wigle, Dennis, Jones, David R , Conti, Massimo , de Perrot, Marc , Mitchell, John D , Jones, David R. , BAUER, THOMAS L , Miller, Daniel , Altorki, Nasser Khaled , Damman, Bryce

Journal of Clinical Oncology | January 12, 2024 | Volume: 42 | Issue: 10 | Pages: 1110-1113

10.1200/jco.23.01306 | PMID 38215351 Get It

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical trial updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. Patients with early-stage non–small-cell lung cancer (NSCLC) who undergo curative surgical resection are at risk for developing second primary lung cancer (SPLC). Cancer and Leukemia Group B 140503 (Alliance) was a multicenter, international, randomized, phase III trial in patients with stage T1aN0 NSCLC (using the TNM staging system seventh edition) and demonstrated the noninferiority for disease-free survival between sublobar resection (SLR) and lobar resection (LR). After surgery, patients underwent computed tomography surveillance as defined by the protocol. The determination of a SPLC was done by the treating physician and recorded in the study database. We performed an analysis of the rate of SPLC (per patient per year) and the 5-year cumulative incidence in the study population and within the SLR and LR arms. Median follow-up was 7 years. The rate per patient per year in the study population, in the SLR arm, and in the LR arm was 3.4% (95% CI, 2.9 to 4.1), 3.8% (95% CI, 2.9 to 4.9), and 3.1% (95% CI, 2.4 to 4.1), respectively. The estimated 5-year cumulative incidence of SPLC in the study population, SLR arm, and LR arm was 15.9% (95% CI, 12.9 to 18.9), 17.2% (95% CI, 12.7 to 21.5), and 14.7% (95% CI, 10.6 to 18.7), respectively.
In Response
Milam, Adam J. , Vandenberg, Megan, Kraus, Molly, Milam, Adam J , Vandenberg, Megan, Kraus, Molly B.

Anesthesia & Analgesia | January 12, 2024 | Volume: 138 | Issue: 2 | Pages: e11-e12

10.1213/ane.0000000000006798 | PMID 38215723 Get It

Public Health Informatics and the Perioperative Physician: Looking to the Future
Gabriel, Rodney A. , Howell, Stephen, Tan, Jonathan M. , O’Reilly-Shah, Vikas N. , Poterack, Karl A. , Rothman, Brian , Poterack, Karl, Mudumbai, Seshadri C. , Howell, Stephen, Freundlich, Robert E. , Kendale, Samir M.

Anesthesia & Analgesia | January 12, 2024 | Volume: 138 | Issue: 2 | Pages: 253-272

10.1213/ane.0000000000006649 | PMID 38215706 Get It

The role of informatics in public health has increased over the past few decades, and the coronavirus disease 2019 (COVID-19) pandemic has underscored the critical importance of aggregated, multicenter, high-quality, near-real-time data to inform decision-making by physicians, hospital systems, and governments. Given the impact of the pandemic on perioperative and critical care services (eg, elective procedure delays; information sharing related to interventions in critically ill patients; regional bed-management under crisis conditions), anesthesiologists must recognize and advocate for improved informatic frameworks in their local environments. Most anesthesiologists receive little formal training in public health informatics (PHI) during clinical residency or through continuing medical education. The COVID-19 pandemic demonstrated that this knowledge gap represents a missed opportunity for our specialty to participate in informatics-related, public health-oriented clinical care and policy decision-making. This article briefly outlines the background of PHI, its relevance to perioperative care, and conceives intersections with PHI that could evolve over the next quarter century.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL
Woyach, Jennifer A. , Burbano, Gabriela Perez , Ruppert, Amy S. , Heerema, Nyla A. , Zhao, Weiqiang , Wall, Anna, Brander, Danielle M. , Rogers, Kerry A. , Stephens, Deborah M. , Brown, Jennifer R. , Lozanski, Gerard , Nattam, Sreenivasa, Litzow, Mark R. , Luger, Selina M. , Owen, Carolyn , Kuzma, Charles, Little, Richard F. , Dinner, Shira, Stone, Richard M. , Uy, Geoffrey L. , Mandrekar, Sumithra J. , Byrd, John C. , Perez Burbano, Gabriela , Barr, Paul M , Rogers, Kerry A , Parikh, Sameer A , Stephens, Deborah M , Blachly, James , Larson, Richard A , Erba, Harry Paul , Litzow, Mark R. , Abramson, Jeremy S , Little, Richard F , Uy, Geoffrey , Byrd, John C , Miller, Cecelia , Ding, Wei , Bartlett, Nancy L. , Barr, Paul M. , Parikh, Sameer A. , Blachly, James S. , Larson, Richard A. , Abramson, Jeremy S. , Stock, Wendy

Blood | January 12, 2024 | Volume: 143 | Issue: 16 | Pages: 1616-1627

10.1182/blood.2023021959 | PMID 38215395 Get It

Abstract A041202 (NCT01886872) is a phase 3 study comparing bendamustine plus rituximab (BR) with ibrutinib and the combination of ibrutinib plus rituximab (IR) in previously untreated older patients with chronic lymphocytic leukemia (CLL). The initial results showed that ibrutinib-containing regimens had superior progression-free survival (PFS) and rituximab did not add additional benefits. Here we present an updated analysis. With a median follow-up of 55 months, the median PFS was 44 months (95% confidence interval [CI], 38-54) for BR and not yet reached in either ibrutinib-containing arm. The 48-month PFS estimates were 47%, 76%, and 76% for BR, ibrutinib, and IR, respectively. The benefit of ibrutinib regimens over chemoimmunotherapy was consistent across subgroups of patients defined by TP53 abnormalities, del(11q), complex karyotype, and immunoglobulin heavy chain variable region (IGHV). No significant interaction effects were observed between the treatment arm and del(11q), the complex karyotype, or IGHV. However, a greater difference in PFS was observed among the patients with TP53 abnormalities. There was no difference in the overall survival. Notable adverse events with ibrutinib included atrial fibrillation (afib) and hypertension. Afib was observed in 11 patients (pts) on BR (3%) and 67 pts on ibrutinib (18%). All-grade hypertension was observed in 95 pts on BR (27%) and 263 pts on ibrutinib (55%). These data show that ibrutinib regimens prolong PFS compared with BR for older patients with treatment-naïve CLL. These benefits were observed across subgroups, including high-risk groups. Strikingly, within the ibrutinib arms, there was no inferior PFS for patients with abnormalities in TP53, the highest risk feature observed in CLL. These data continue to demonstrate the efficacy of ibrutinib in treatment-naïve CLL.
Acupuncture as a Complementary Treatment Modality in the Post-Anesthesia Care Setting: A Feasibility Study
Harbell, Monica W. , Barendrick, Lindsay N., Pelkey, Melissa N. , Elam, Debbie E., Bombaci, Nikki A., Mora, Kerri S., Mi, Lanyu , Quillen, Jaxon , Millstine, Denise , Millstine, Denise M, Harbell, Monica W , Pelkey, Melissa N , Barendrick, Lindsay N.

Journal of Integrative and Complementary Medicine | January 12, 2024 | Volume: 30 | Issue: 8 | Pages: 776-782

10.1089/jicm.2023.0168 | PMID 38215309 Get It

Introduction: Postoperative pain management and postoperative nausea and vomiting are a persistent challenge for both health care providers and patients. Acupuncture is an effective and safe modality for the management of pain and nausea, and has the potential to play a key role in postoperative pain management. This study explores the utility and feasibility of acupuncture in the immediate postoperative setting. Methods: In a retrospective case–control study, 22 patients who underwent elective surgeries and received acupuncture in the post-anesthesia care unit (PACU) were compared with 88 case controls. Indications for acupuncture therapy included persistent pain, nausea, or anxiety. Patient satisfaction and symptom improvement after acupuncture were assessed. PACU nurses and patients were queried on their perspectives on using this therapy. Demographic data, perioperative opioid consumption, pain score in the PACU, incidence of postoperative nausea, PACU length of stay, and unintended hospital admission were assessed. The groups with/without acupuncture were compared using Wilcoxon rank sum test or Fisher's exact test as appropriate. Results: A total of 78.9% of patients receiving acupuncture felt improvement in their symptoms. 94.7% of recovery nurses who cared for patients who received acupuncture felt that it was helpful and 78.9% did not believe it was disruptive. Patients who opted for acupuncture had a statistically significant higher overall median (interquartile range) pain score in the PACU (7.0 [5.2, 9.5] vs. 5.0 [3.0, 7.0], p = 0.009) and higher postoperative opioid consumption (22.5 [9.8, 44.8] vs. 15.0 [0.0, 30.0], p = 0. 03). There was no difference between total perioperative opioid consumption between groups ( p = 0.94). Conclusions: Most patients who received acupuncture therapy in the PACU were satisfied with their therapy and would recommend it to future patients undergoing surgery. Most recovery nurses felt it was helpful, was not disruptive, and would like to see it utilized in the PACU.